Inconclusive St. John’s Wort Trial Prompts Queries On Study Design, Setting
This article was originally published in The Tan Sheet
Executive Summary
The inconclusive nature of a recent study on St. John's wort suggests the current procedure for funding and designing clinical trials of botanicals may need to be reexamined, according to a letter in the July 24 Journal of the American Medical Association
You may also be interested in...
Supplement Dose Escalation Trials Help Foster Success – NCCAM’s Berman
Initial dose escalation trials will improve the success rate of dietary supplement clinical trials, according to director of NCCAM's Office of Clinical & Regulatory Affairs, Jonathan Berman, MD, PhD
Supplement Dose Escalation Trials Help Foster Success – NCCAM’s Berman
Initial dose escalation trials will improve the success rate of dietary supplement clinical trials, according to director of NCCAM's Office of Clinical & Regulatory Affairs, Jonathan Berman, MD, PhD
Supplement Dose Escalation Trials Help Foster Success – NCCAM’s Berman
Initial dose escalation trials will improve the success rate of dietary supplement clinical trials, according to director of NCCAM's Office of Clinical & Regulatory Affairs, Jonathan Berman, MD, PhD